Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.00
Bid: 1,594.50
Ask: 1,595.50
Change: -19.00 (-1.17%)
Spread: 1.00 (0.063%)
Open: 1,608.00
High: 1,615.00
Low: 1,575.00
Prev. Close: 1,618.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 11th Mar 2013 07:23

Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling.Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral.Anite Group: Invetsec downgrades from buy to hold with a target price of 157p.Aviva: Citigroup reduces target price from 479p to 432p reiterating its buy recommendation. Bank of America shifts target price from 330p to 350p, while its neutral rating is maintained.Avocet Mining: Investec cuts target price from 28.60p to 24p and keeps a hold recommendation.Babcock: JP Morgan ups target price from 1120p to 1230p, while maintaining an overweight rating.Bovis Homes: UBS increases target price from 560p to 700p retaining a neutral rating.BP: Deutsche Bank moves target price from 500p to 520p, while leaving its buy recommendation unaltered.British American Tabacco: Investec raises target price from 3350p to 3800p reiterating a buy recommendation.Capita: Westhouse Securities takes target price from 661p to 755p, while maintaining a sell recommendation.CAP-XX: Having had both its target price and recommendation under review, Cantor Fitzgerald rates a target price of 13p and a buy recommendation.Carillion: UBS lowers target price from 240p to 230p and reiterates a sell recommendation.Chime Communications: Investec ups target price from 265p to 300p and keeps a buy recommendation.Clinigen Group: Numis revises target price from 265p to 310p and stays with its buy recommendation.Cobham: Morgan Stanley ups target price from 175p to 195p and maintains an underweight rating. Exane BNP moves target price from 205p to 230p, while staying with its neutral rating.Daily Internet: Merchant Securities initiates with a target price of 8p and a buy recommendation.Dixons Retail: Deutsche Bank shifts target price from 31p to 36p keeping a buy recommendation.Escher Group: Panmure Gordon increases target price from 384p to 410p, while maintaining a buy recommendation.GlaxoSmithKline: Deutsche Bank increases target price from 1440p to 1530p and retains a hold recommendation. Espirito Santo shifts target price from 525p to 533p, while keeping a neutral rating.Hammerson: UBS moves target price from 525p to 560p, while leaving its buy recommendation unchanged.Herencia Resources: WH Ireland downgrades from buy to a speculative buy.HG Capital Trust: Oriel Securities revises target price from 1065p to 1130p and stays with its hold recommendation.Hiscox: Westhouse Securities ups target price from 525p to 533p reiterating a neutral rating.Howden Joinery: Numis raises target price from 245p to 260p keeping an add rating.HSBC Holdings: Exane BNP cuts target price from 850p to 825p and stays with its outperform rating.Hunting: Liberum Capital raises target price from 770p to 826p, while its hold recommendation is kept.ICAP: UBS reduces target price from 330p to 305p and downgrades from neutral to sell.IMI: UBS revises target price from 1000p to 1100p, but still recommends selling.Intu Properties: Espirito Santo reduces target price from 320p to 295p keeping a sell recommendation.Ladbrokers: Panmure Gordon raises target price from 195p to 219p, while maintaining a hold recommendation. Bank of America moves target price from 235p to 260p and retains its buy recommendation.Lloyds Banking Group: Bank of America shifts target price from 65p to 70p and retains its buy recommendation.Marshalls: Citigroup moves target price from 96p to 110p staying with its neutral rating.Perform: JP Morgan raises target price from 416p to 451p and keeps its neutral rating.Petro Matad: Westhouse Securities upgrades from add to buy with a target price of 15p.Playtech: Deutsche Bank takes target price from 550p to 650p and stays with its buy recommendation.Pure Water: WH Ireland shifts target price from 8.25p to 9.75p and maintains a buy recommendation.Reckitt Benckiser: Bank of America raises target price from 5000p to 5250p and reiterates its buy recommendation.Sage: Analysts at Bank of America-Merrill Lynch have downgraded their view to underperform. Bank of America shifts target price from 320p to 330p, while downgrading to underperform.Schroders: Credit Suisse ups target price from 1800p to 2150p keeping a neutral rating.Standard Chartered: Exane BNP revises target price from 1700p to 1750op leaving its neutral rating unchanged.Standard Life: Bank of America increases target price from 340p to 375p keeping an underperform rating.SThree: Numis downgrades to hold with a target price of 350p.St Ives: Numis moves target price from 132p to 150p reiterating its buy recommendation.St Modwen Properties: Numis revises target price from 259p to 280p and downgrades to add.Tullet Prebon: UBS shifts target price from 244p to 250p, while downgrading from neutral to sell.UBM: UBS ups target price from 700p to 740p and reiterates a neutral rating. Citigroup moves target price from 734p to 749p, while its neutral rating is kept.William Hill: Bank of America takes target price from 315p to 420p and leaves its underperform rating unaltered.Wolseley: UBS raises target price from 2800p to 3375p and keeps a neutral rating.
More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.